The Ontario COVID-19 Science Advisory Table is a group of scientific experts and health system leaders who evaluate and report on emerging evidence relevant to the COVID-19 pandemic, to inform Ontario’s response.
Published: April 26, 2021
Presenters: Laveena Munshi MD MSc, Stephanie Carlin PharmD, Beth Leung PharmD MsCI
Moderator: Brad Langford PharmD
Summarize the data on the use of tocilizumab in patients with COVID-19
Describe the recommended populations to receive tocilizumab
Provide advice and considerations regarding secondary infections
Discuss access and use of tocilizumab in the context of a shortage situation
Watch the full webinar here.